Toll-like receptors: promising therapeutic targets for inflammatory diseases (Q38925152)

7 September 2017

1 reference

title

Toll-like receptors: promising therapeutic targets for inflammatory diseases (English)

1 reference

7 September 2017

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Asma Achek

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Dhanusha Yesudhas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

11 August 2016

1 reference

Archives of Pharmacal Research

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

1032-1049

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12272-016-0806-9

12 June 2020

exact match

0 references

cites work

Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Negative regulatory approaches to the attenuation of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Sterile-α- and armadillo motif-containing protein inhibits the TRIF-dependent downregulation of signal regulatory protein α to interfere with intracellular bacterial elimination in Burkholderia pseudomallei-infected mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor modulators: a patent review (2006-2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Induction of Experimental Arthritis by Borrelial Lipoprotein and CpG Motifs: Are Toll-Like Receptors 2, 4, 9 or CD-14 Involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Dual role of Toll-like receptors in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Intestinal epithelium-specific MyD88 signaling impacts host susceptibility to infectious colitis by promoting protective goblet cell and antimicrobial responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Intracellular toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-Like Receptor Pathways in Autoimmune Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Endosomal Toll-like receptors in clinically overt and silent autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptors in the pathogenesis of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 4 polymorphisms and atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Th17 cells: new players in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Associations of toll-like receptor (TLR)-4 single nucleotide polymorphisms and rheumatoid arthritis disease progression: an observational cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptors: Activation, signalling and transcriptional modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

A specific role for TLR1 in protective T(H)17 immunity during mucosal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Innate and adaptive immunity and the pathophysiology of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Assembly and localization of Toll-like receptor signalling complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Targeting toll-like receptors for drug development: a summary of commercial approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Innate and adaptive immunity in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Mechanisms underlying inflammation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptors: role in dermatological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Innate immunity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

The role of airway epithelial cells and innate immune cells in chronic respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Structures of the toll-like receptor family and its ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor downstream signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

DUBA: a deubiquitinase that regulates type I interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptors as targets for immune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

IRAK-M is a negative regulator of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor heterodimer variants protect from childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Pathogen recognition by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and -9 expression with the involvement of MAPKs and NF-kappaB in human epidermal keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

A novel antagonist of TLR9 blocking all classes of immunostimulatory CpG-ODNs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Negative regulation of toll-like receptor-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

State-of-the-art: rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

The role of toll-like receptors in the pathogenesis and treatment of dermatological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Recognition of microorganisms and activation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

IRAK2 takes its place in TLR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TGF-alpha regulates TLR expression and function on epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLRs and chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Inflammation: Species-specific TLR signalling -- insight into human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

A synthetic lipid A mimetic modulates human TLR4 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

DAMPening inflammation by modulating TLR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Regulation of Toll-like receptor signaling pathways in innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TAM receptors are pleiotropic inhibitors of the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Differences in airway cytokine profile in severe asthma compared to moderate asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Neutralization of pro-inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptors are potential therapeutic targets in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

TLR4-induced IFN-gamma production increases TLR2 sensitivity and drives Gram-negative sepsis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Microglia as neuroprotective, immunocompetent cells of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Th17 cells in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Emerging role of endosomal toll-like receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Differential expression of toll-like receptor mRNA in selected tissues of goat (Capra hircus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Aldara activates TLR7-independent immune defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Multiple roles of toll-like receptor 4 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Structural basis of TLR5-flagellin recognition and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

Expression and Functional Analysis of Toll-Like Receptors of Peripheral Blood Cells in Asthmatic Patients: Implication for Immunopathological Mechanism in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0806-9

10.1007/S12272-016-0806-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27515048%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 June 2020

1046670377

0 references

Fatcat ID

release_vba63ccidbhijfcdv6sd5oh34q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vba63ccidbhijfcdv6sd5oh34q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference